Results 141 to 150 of about 10,491 (187)

Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-naïve people with HIV-1: a systematic literature review and network meta-analysis. [PDF]

J Comp Eff Res
Curteis T, Eddowes LA, Chen M, Gandhi-Patel B, Karlsson A, Luedke H, Rubinstein M, Hempfling M, Scerpella EG, Chaudhari P, Jarrett J.   +10 more
europepmc   +1 more source

Maternal HIV Infection and Antiretroviral Therapy in Pregnancy: Implications for Vertical Transmission, Fetal Safety, and Long-Term Infant Outcomes. [PDF]

Pathogens
Fleșeriu T, Meliț LE, Mărginean CO, Pop AV, Văsieșiu AM.   +4 more
europepmc   +1 more source

Heterogeneous Antiretroviral Drug Exposure in Male and Female Genital Tract Tissues. [PDF]

J Infect Dis
Rosen EP, White N, Sykes C, Adamson L, Luciw P, Norris A, Fedoriw Y, Kashuba ADM.   +7 more
europepmc   +1 more source

Comparative effectiveness and safety of integrase strand transfer inhibitor (INSTI)-based versus non-INSTI-based antiretroviral regimens in treatment-naïve people with HIV: A real-world retrospective cohort study. [PDF]

Medicine (Baltimore)
Ye X, Han J, Zhang Y, Yang C, Zuo Z, Huang L, Hu L, Lei J, Wang M, Cui H, Chen X.   +10 more
europepmc   +1 more source

Correction: Optimising Paediatric HIV Treatment: Recent Developments and Future Directions. [PDF]

Paediatr Drugs
Kamphuis AEM, Bamford A, Tagarro A, Cressey TR, Bekker A, Amuge P, Mujuru HA, Ndongo FA, Diack A, Compagnucci A, Lallemant M, Colbers A, Turkova A.   +12 more
europepmc   +1 more source

Repurposing raltegravir for reducing inflammation and treating cancer: a bioinformatics analysis. [PDF]

Sci Rep
Nikfarjam Z, Rakhshi R, Zargari F, Aalikhani M, Hasan-Abad AM, Bazi Z.   +5 more
europepmc   +1 more source

Breastfeeding on ART and a closer look at drug transfer to HIV-exposed uninfected infants. [PDF]

Sci Rep
Spielberger BD, Zink A, Rohr JC, Usadel S, Klinker H, Freudenhammer M, Elling R, Rieg S, Henneke P, Hufnagel M, Müller MC.   +10 more
europepmc   +1 more source

How should APOBEC3-induced resistance mutations be considered in the management of antiretroviral therapy? [PDF]

J Antimicrob Chemother
Gilbert M, Ferré VM, Guilbaud R, Digumber M, Peytavin G, Damond F, Le Hingrat Q, Yazdanpanah Y, Descamps D, Charpentier C, Joly V, Ghosn J.   +11 more
europepmc   +1 more source

Noninvasive Markers of Hepatic Steatosis and Fibrosis Following Integrase Strand-Transfer Inhibitor Initiation in Women With HIV. [PDF]

Clin Infect Dis
Yu MA, Gerig L, Mehta CC, Musonge-Effoe J, Alvarez JA, Ofotokun I, Sheth AN, Ali MK, Ziegler TR, Yang Q, Spence AB, Alcaide ML, Dumond JB, Abraham AG, French AL, Augenbraun M, Anastos K, Price JC, Tien PC, Lahiri CD.   +19 more
europepmc   +1 more source